NMRA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. While NMRA seems to be doing ok healthwise, there are quite some concerns on its profitability. NMRA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

NMRA had negative earnings in the past year.
In the past year NMRA has reported a negative cash flow from operations.
In the past 5 years NMRA always reported negative net income.
In the past 5 years NMRA always reported negative operating cash flow.

1.2 Ratios

NMRA's Return On Assets of -132.88% is on the low side compared to the rest of the industry. NMRA is outperformed by 84.29% of its industry peers.
With a Return On Equity value of -178.79%, NMRA is not doing good in the industry: 72.77% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-132.88%
ROE	-178.79%
ROIC	N/A

ROA(3y)-51.72%

ROA(5y)-52.12%

ROE(3y)-56.07%

ROE(5y)-55.97%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NMRA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, NMRA has more shares outstanding
The number of shares outstanding for NMRA has been increased compared to 5 years ago.
NMRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -7.84, we must say that NMRA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.84, NMRA is doing worse than 69.11% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that NMRA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, NMRA is in line with its industry, outperforming 48.17% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	-7.84

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NMRA has a Current Ratio of 6.85. This indicates that NMRA is financially healthy and has no problem in meeting its short term obligations.
NMRA has a better Current ratio (6.85) than 70.68% of its industry peers.
NMRA has a Quick Ratio of 6.85. This indicates that NMRA is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 6.85, NMRA is doing good in the industry, outperforming 71.20% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.85
Quick Ratio	6.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.99% over the past year.

EPS 1Y (TTM)22.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.89%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NMRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.07% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y5.05%

EPS Next 2Y15.18%

EPS Next 3Y10%

EPS Next 5Y13.07%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NMRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NMRA. No positive earnings are expected for the next year.